Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China · Delayed Price · Currency is CNY 15.73
-0.43 (-2.66%)
Sep 11, 2026, 3:04 PM CST
SHE:300482 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 302.49 | 462.53 | 828.69 | 840.3 | 1,163 | 996.15 |
Short-Term Investments | 518.15 | 374.35 | 62.86 | 623.04 | 200.26 | - |
Trading Asset Securities | 1,796 | 1,264 | 1,306 | 722.45 | 938.07 | 572.73 |
Cash & Short-Term Investments | 2,617 | 2,101 | 2,198 | 2,186 | 2,301 | 1,569 |
Cash Growth | 56.98% | -4.39% | 0.55% | -5.00% | 46.66% | 3.84% |
Accounts Receivable | 697.13 | 791.88 | 1,130 | 599.87 | 540.97 | 501.78 |
Other Receivables | 59.84 | 49.26 | 44.25 | 51.72 | 66.6 | 64.7 |
Receivables | 756.97 | 841.14 | 1,174 | 651.59 | 607.57 | 566.48 |
Inventory | 323.43 | 280.58 | 359.56 | 351.4 | 399.97 | 386.24 |
Other Current Assets | 78.23 | 78.22 | 54.17 | 44.57 | 42 | 63.9 |
Total Current Assets | 3,775 | 3,301 | 3,786 | 3,233 | 3,350 | 2,586 |
Property, Plant & Equipment | 1,387 | 1,454 | 1,484 | 1,353 | 1,189 | 906.09 |
Long-Term Investments | 1,074 | 1,316 | 1,391 | 709.48 | 1,284 | 971.42 |
Goodwill | 108.97 | 108.97 | 111.42 | 111.42 | 115.37 | 42.51 |
Other Intangible Assets | 241.15 | 245.69 | 205.51 | 194.52 | 203.71 | 208.11 |
Long-Term Deferred Tax Assets | 90.88 | 112.69 | 76.18 | 57.47 | 53.86 | 42.77 |
Long-Term Deferred Charges | 40.37 | 41.02 | 56.46 | 80.03 | 65.04 | 69.76 |
Other Long-Term Assets | 16.98 | 22.34 | 44.59 | 32.83 | 39.41 | 29.66 |
Total Assets | 6,741 | 6,602 | 7,155 | 5,772 | 6,301 | 4,856 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 265.52 | 210.81 | 288.37 | 130.46 | 320.08 | 399.99 |
Accrued Expenses | 100.12 | 105.45 | 201.41 | 193.5 | 229.74 | 184.01 |
Short-Term Debt | - | 0.01 | 14.85 | 4.26 | 208.42 | 19.14 |
Current Portion of Long-Term Debt | 602.69 | 588.39 | - | - | - | 12.53 |
Current Portion of Leases | 3.54 | 3.99 | 5.41 | 19.01 | 16.86 | 28.24 |
Current Income Taxes Payable | 0.1 | 0.46 | 42.6 | 21.84 | 58.73 | 4.69 |
Current Unearned Revenue | 106.73 | 75.66 | 77.1 | 72.88 | 236.31 | 80.55 |
Other Current Liabilities | 60.01 | 54.11 | 191.73 | 42.29 | 70.91 | 62.4 |
Total Current Liabilities | 1,139 | 1,039 | 821.46 | 484.23 | 1,141 | 791.54 |
Long-Term Debt | - | - | 570.97 | 552.84 | 532.49 | 510.69 |
Long-Term Leases | 7.27 | 9.26 | 14.33 | 27.69 | 11.19 | 10.42 |
Long-Term Unearned Revenue | 46.3 | 44.54 | 47.94 | 37.21 | 23.1 | 9.4 |
Long-Term Deferred Tax Liabilities | 29.37 | 35.44 | 49.66 | 55.12 | 55.75 | 29.7 |
Total Liabilities | 1,232 | 1,128 | 1,504 | 1,157 | 1,764 | 1,352 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 468.09 | 468.08 | 481.42 | 444.52 | 444.51 | 444.95 |
Additional Paid-In Capital | 1,404 | 1,399 | 1,458 | 765.52 | 775.53 | 787.01 |
Retained Earnings | 3,577 | 3,557 | 3,807 | 3,433 | 3,166 | 2,101 |
Treasury Stock | -30.09 | -30.09 | -171.02 | -132.46 | -157.3 | -139.25 |
Comprehensive Income & Other | 28.21 | 21.2 | -21.29 | 5.9 | 115.39 | 159.18 |
Total Common Equity | 5,447 | 5,415 | 5,554 | 4,516 | 4,344 | 3,353 |
Minority Interest | 61.57 | 58.93 | 95.9 | 98.66 | 193.8 | 150.97 |
Shareholders' Equity | 5,508 | 5,474 | 5,650 | 4,615 | 4,538 | 3,504 |
Total Liabilities & Equity | 6,741 | 6,602 | 7,155 | 5,772 | 6,301 | 4,856 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 613.5 | 601.65 | 605.57 | 603.8 | 768.96 | 581.01 |
Net Cash (Debt) | 2,003 | 1,500 | 1,592 | 1,582 | 1,532 | 987.87 |
Net Cash Growth | 88.34% | -5.81% | 0.65% | 3.27% | 55.07% | 9.88% |
Net Cash Per Share | 4.19 | 3.09 | 3.43 | 3.57 | 3.47 | 2.23 |
Filing Date Shares Outstanding | 473.6 | 506.3 | 477.87 | 440.96 | 441.26 | 444.95 |
Total Common Shares Outstanding | 473.6 | 506.3 | 477.87 | 440.96 | 441.26 | 444.95 |
Working Capital | 2,637 | 2,262 | 2,964 | 2,749 | 2,209 | 1,794 |
Book Value Per Share | 11.50 | 10.69 | 11.62 | 10.24 | 9.84 | 7.54 |
Tangible Book Value | 5,097 | 5,060 | 5,237 | 4,210 | 4,025 | 3,102 |
Tangible Book Value Per Share | 10.76 | 9.99 | 10.96 | 9.55 | 9.12 | 6.97 |
Buildings | 996.91 | 997.33 | 1,007 | 530.37 | 447.3 | 436.03 |
Machinery | 1,089 | 1,113 | 1,071 | 1,021 | 940.43 | 741.37 |
Construction In Progress | 18.36 | 17.25 | 5.12 | 290.84 | 199.14 | 16.38 |